Microdosing

Microdosing involves taking sub-perceptual doses of psychoactive substances — typically 5-10% of a full recreational dose — on a structured schedule. The goal is to access subtle cognitive and mood benefits without obvious impairment or altered consciousness [1]. Most microdosing protocols follow a pattern like James Fadiman's approach: dose every third day to avoid tolerance while maintaining baseline function.

Neurologically, we're looking at threshold activation of key receptor systems without overwhelming them. With classical psychedelics, this means gentle 5-HT2A receptor engagement that may enhance neuroplasticity and default mode network flexibility [2]. For other substances, the mechanisms vary — stimulant microdoses might optimize dopamine signaling, while anxiolytic compounds could modulate GABA activity just enough to reduce background anxiety.

The appeal lies in accessing what users describe as increased focus, emotional resilience, and creative problem-solving while remaining fully functional. Think of it as tuning your neurochemistry rather than dramatically altering it. However, the line between "sub-perceptual" and "mildly active" is individual and dose-dependent — what feels like nothing to one person might be clearly noticeable to another.